These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22532874

  • 1. pVHL mediates K63-linked ubiquitination of nCLU.
    Xue J, Lv DD, Jiao S, Zhao W, Li X, Sun H, Yan B, Fan L, Hu RG, Fang J.
    PLoS One; 2012; 7(4):e35848. PubMed ID: 22532874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. USP9X destabilizes pVHL and promotes cell proliferation.
    Zhang C, Peng Z, Zhu M, Wang P, Du X, Li X, Liu Y, Jin Y, McNutt MA, Yin Y.
    Oncotarget; 2016 Sep 13; 7(37):60519-60534. PubMed ID: 27517496
    [Abstract] [Full Text] [Related]

  • 5. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein.
    Corn PG, McDonald ER, Herman JG, El-Deiry WS.
    Nat Genet; 2003 Nov 13; 35(3):229-37. PubMed ID: 14556007
    [Abstract] [Full Text] [Related]

  • 6. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein.
    Nakamura E, Abreu-e-Lima P, Awakura Y, Inoue T, Kamoto T, Ogawa O, Kotani H, Manabe T, Zhang GJ, Kondo K, Nosé V, Kaelin WG.
    Am J Pathol; 2006 Feb 13; 168(2):574-84. PubMed ID: 16436671
    [Abstract] [Full Text] [Related]

  • 7. pVHL mediates K63-linked ubiquitination of IKKβ, leading to IKKβ inactivation.
    Wang Y, Zhao W, Gao Q, Fan L, Qin Y, Zhou H, Li M, Fang J.
    Cancer Lett; 2016 Dec 01; 383(1):1-8. PubMed ID: 27693634
    [Abstract] [Full Text] [Related]

  • 8. pVHL interacts with Ceramide kinase like (CERKL) protein and ubiquitinates it for oxygen dependent proteasomal degradation.
    Chen J, Liu F, Li H, Archacki S, Gao M, Liu Y, Liao S, Huang M, Wang J, Yu S, Li C, Tang Z, Liu M.
    Cell Signal; 2015 Nov 01; 27(11):2314-23. PubMed ID: 26296657
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. pVHL's kryptonite: E2-EPF UCP.
    Ohh M.
    Cancer Cell; 2006 Aug 01; 10(2):95-7. PubMed ID: 16904608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.
    Okuda H, Saitoh K, Hirai S, Iwai K, Takaki Y, Baba M, Minato N, Ohno S, Shuin T.
    J Biol Chem; 2001 Nov 23; 276(47):43611-7. PubMed ID: 11574546
    [Abstract] [Full Text] [Related]

  • 14. Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.
    Foy RL, Chitalia VC, Panchenko MV, Zeng L, Lopez D, Lee JW, Rana SV, Boletta A, Qian F, Tsiokas L, Piontek KB, Germino GG, Zhou MI, Cohen HT.
    Hum Mol Genet; 2012 Dec 15; 21(26):5456-71. PubMed ID: 23001567
    [Abstract] [Full Text] [Related]

  • 15. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.
    Li Z, Na X, Wang D, Schoen SR, Messing EM, Wu G.
    J Biol Chem; 2002 Feb 15; 277(7):4656-62. PubMed ID: 11739384
    [Abstract] [Full Text] [Related]

  • 16. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
    Hansen WJ, Ohh M, Moslehi J, Kondo K, Kaelin WG, Welch WJ.
    Mol Cell Biol; 2002 Mar 15; 22(6):1947-60. PubMed ID: 11865071
    [Abstract] [Full Text] [Related]

  • 17. PKCzetaII is a target for degradation through the tumour suppressor protein pVHL.
    Iturrioz X, Parker PJ.
    FEBS Lett; 2007 Apr 03; 581(7):1397-402. PubMed ID: 17350623
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.
    Liu W, Xin H, Eckert DT, Brown JA, Gnarra JR.
    Oncogene; 2011 Jan 06; 30(1):21-31. PubMed ID: 20802534
    [Abstract] [Full Text] [Related]

  • 19. The von Hippel-Lindau protein pVHL inhibits ribosome biogenesis and protein synthesis.
    Zhao WT, Zhou CF, Li XB, Zhang YF, Fan L, Pelletier J, Fang J.
    J Biol Chem; 2013 Jun 07; 288(23):16588-16597. PubMed ID: 23612971
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
    Miller F, Kentsis A, Osman R, Pan ZQ.
    J Biol Chem; 2005 Mar 04; 280(9):7985-96. PubMed ID: 15611064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.